Literature DB >> 1568180

A study of 15 cases of primary mediastinal lymphoma of B-cell type.

T Lavabre-Bertrand1, D Donadio, N Fegueux, D Jessueld, J Taib, D Charlier, T Rousset, J M Emberger, P Baldet, M Navarro.   

Abstract

Fifteen cases of pure supradiapragmatic lymphoma with initial prominent antero-superior mediastinal involvement displaying a B-cell pattern of reactivity were studied. These cases occurred in six men and nine women with a median age of 33 years at diagnosis (range, 23 to 75 years). Supradiapragmatic peripheral lymphadenopathies were present in three cases, and intrathoracic extension to the lung, pericardium, or pleura was possible. In five cases a thymic origin was obvious. All cases exhibited a B-cell pattern of differentiation, with a great variety of histopathologic aspects associated with a high frequency of fibrosis and/or necrosis. Hodgkin's disease was initially misdiagnosed in four cases. The evolution was purely local, with extrathoracic extension in five cases, at the ultimate phase of the disease. The prognosis appeared to be poor with only five patients still alive at a median survival time of 16 months. A complete chemoresistance and radio-resistance was observed in seven cases; only two complete remissions were achieved with aggressive chemotherapy. Prolonged remission could be achieved after surgical reduction of the mass. Primary B-cell mediastinal lymphoma appears to be a distinct clinical entity with local evolution and resistance to therapy. A new therapeutic regimen, which could include surgery in some cases, should be found for this disease.

Entities:  

Mesh:

Year:  1992        PMID: 1568180     DOI: 10.1002/1097-0142(19920515)69:10<2561::aid-cncr2820691028>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Current guidelines for the management of aggressive non-Hodgkin's lymphoma.

Authors:  M Martelli; V De Sanctis; G Avvisati; F Mandelli
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

2.  Primary mediastinal large B-cell lymphoma: a comparative study with nodular sclerosis-type Hodgkin's disease.

Authors:  N Yonetani; M Kurata; M Nishikori; H Haga; K Ohmori; H Yamabe; T Uchiyama; H Ohno
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

3.  Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

Authors:  Stefano A Pileri; Gianluca Gaidano; Pier Luigi Zinzani; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Federica Pieri; Eva Berra; Elena Sabattini; Stefano Ascani; Milena Piccioli; Peter W M Johnson; Roberto Giardini; Edoardo Pescarmona; Domenico Novero; Pier Paolo Piccaluga; Teresa Marafioti; Miguel A Alonso; Franco Cavalli
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

4.  Immunophenotyping of Non-Hodgkin's lymphomas in Sudan.

Authors:  Khalid Hamad Hamid; Adel Hussein Elduma; Badereldin Mirgani Yousif Mohamed; Magdi Mansour Abdel Farage Salih
Journal:  Pan Afr Med J       Date:  2014-05-24

5.  Primary mediastinal lymphomas, their morphological features and comparative evaluation.

Authors:  Riti Aggarwal; Seema Rao; Shashi Dhawan; Sunita Bhalla; Arvind Kumar; Prem Chopra
Journal:  Lung India       Date:  2017 Jan-Feb

6.  Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.

Authors:  Andreas Rosenwald; George Wright; Karen Leroy; Xin Yu; Philippe Gaulard; Randy D Gascoyne; Wing C Chan; Tong Zhao; Corinne Haioun; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Elias Campo; Emili Montserrat; Armando Lopez-Guillermo; German Ott; H Konrad Muller-Hermelink; Joseph M Connors; Rita Braziel; Thomas M Grogan; Richard I Fisher; Thomas P Miller; Michael LeBlanc; Michael Chiorazzi; Hong Zhao; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Louis M Staudt
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

7.  Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.

Authors:  Hyun-Jung Kim; Hee Kyung Kim; Gyeongsin Park; Soo Kee Min; Hee Jeong Cha; Hyekyung Lee; Suk Jin Choi; Hee Young Na; Ji-Young Choe; Ji Eun Kim
Journal:  Diagn Pathol       Date:  2019-12-12       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.